Table 1.
Demographic and Clinical Characteristics of Adolescents With MDD and Healthy Controls
Mean (SD) [Range]
|
||||
---|---|---|---|---|
All MDD (n = 20) | Anhedonic MDD (n = 10) | Nonanhedonic MDD (n = 10) | Healthy Controls (n = 21) | |
Characteristic | ||||
Age, y | 16.7 (2.7) [12–19] | 18.0 (1.9) [14–19]a | 15.3 (2.7) [12–19]a | 16.2 (1.6) [13–19] |
Sex, No. (%) | ||||
M | 8 (40) | 4 (40) | 4 (40) | 6 (32) |
F | 12 (60) | 6 (60) | 6 (60) | 15 (68) |
IQ | 106.2 (11.3) | 109.8 (10.7)a | 102.5 (11.2)a | 110.0 (11.6) |
Ethnicity, No. (%) | ||||
White | 8 (40) | 5 (50) | 3 (30) | 9 (43) |
African American | 2 (10) | 0 | 2 (20) | 7 (33) |
Hispanic | 8 (40) | 3 (30) | 5 (50) | 0 |
Asian | 0 | 0 | 0 | 3 (14) |
Other | 2 (10) | 2 (20) | 0 | 2 (10) |
Illness history | ||||
Episode duration, mo | 11.7 (8.6) [2–36] | 13.1 (10.7) [4–36] | 10.2 (6.0) [2–21] | 0 |
No. of episodes | 1.4 (0.6) [1–3] | 1.6 (0.7) [1–3] | 1.2 (0.4) [1–2] | 0 |
Suicide attempts | 0.3 (0.6) [0–2] | 0.1 (0.3) [0–1] | 0.4 (0.7) [0–2] | 0 |
Medication naive, No. (%) | 15 (75) | 6 (60) | 9/1 (90) | 21 (100) |
Medication free, No. (%) | 5 (25) | 4 (40) | 1 (10) | 0 |
Melancholic subtype, No. (%) | 3 (15) | 3 (30) | 0 | 0 |
CDRS-R score | 52.6 (7.5) [38–68] | 56.9 (6.9) [43–68]a | 48.3 (5.5) [38–58]a | 18.8 (1.1) [17–21] |
BDI-II score | 30.1 (12.7) [12–51] | 31.8 (13.6) [17–51] | 28.4 (12.2) [12–47] | 2.6 (3.0) [0–10] |
Anhedonia score | 7.7 (2.5) [3–11] | 8.3 (2.2) [5–11] | 7.0 (2.6) [3–11] | 1.3 (0.6) [1–3] |
Current comorbidity, No. (%) | ||||
ADHD | 4 (20) | 2 (20) | 2 (20) | 0 |
Any anxiety disorder | 11 (55) | 6 (60) | 5 (50) | 0 |
GAD | 11 (55) | 6 (60) | 5 (50) | 0 |
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BDI-II; Beck Depression Inventory, second edition; CDRS-R; Children’s Depression Rating Scale–Revised; GAD, generalized anxiety disorder; MDD, major depressive disorder.
Anhedonic and nonanhedonic MDD subgroups differed significantly with respect to age (P = .02), ethnicity, and MDD severity (P = .007).